Journal of Pathogens

Scope & Guideline

Connecting Global Minds in Infectious Disease Research

Introduction

Welcome to your portal for understanding Journal of Pathogens, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2090-3057
PublisherHINDAWI LTD
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJ PATHOG / J. Pathog.
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The 'Journal of Pathogens' focuses on advancing the understanding of various pathogens and their interactions with hosts, with an emphasis on both clinical and environmental aspects of infectious diseases. The journal aims to disseminate significant research findings that contribute to the fields of microbiology, immunology, and epidemiology.
  1. Pathogen-Host Interactions:
    Research on the molecular and cellular mechanisms through which pathogens interact with host organisms, including studies on immune responses and pathogenicity factors.
  2. Antimicrobial Resistance:
    Investigations into the patterns of resistance exhibited by various pathogens, including the mechanisms of resistance and their clinical implications.
  3. Infectious Disease Epidemiology:
    Studies that examine the prevalence, distribution, and determinants of infectious diseases in populations, often focusing on specific demographics or geographic regions.
  4. Innovative Therapeutics and Treatments:
    Research that explores new therapeutic approaches, including herbal formulations and novel drug compounds, aimed at treating infections caused by resistant pathogens.
  5. Clinical Microbiology:
    Papers that provide insights into the diagnosis, treatment, and management of infectious diseases, particularly in vulnerable populations like pediatric or immunocompromised patients.
The 'Journal of Pathogens' has identified and embraced several emerging themes in its recent publications, reflecting the evolving landscape of infectious disease research. These themes are crucial for informing future studies and public health strategies.
  1. CRISPR and Genetic Editing Technologies:
    The use of CRISPR/Cas9 technology in studying pathogen interactions and resistance mechanisms is gaining traction, indicating a trend towards advanced genetic tools in microbiological research.
  2. Herbal and Alternative Therapeutics:
    There is an increasing interest in exploring the therapeutic potential of herbal formulations and natural products, particularly in the context of antibiotic-resistant infections.
  3. Infectious Diseases in Vulnerable Populations:
    Research focusing on the impact of infectious diseases in vulnerable groups, such as refugees or immunocompromised patients, is emerging as a significant area of study, highlighting public health disparities.
  4. Biofilm Formation and Resistance Mechanisms:
    The exploration of biofilm production by pathogens and its implications for antibiotic treatment is becoming more prominent, reflecting a deeper understanding of chronic infections and treatment challenges.
  5. Comprehensive Resistance Profiling:
    There is a growing emphasis on comprehensive studies that assess both antimicrobial resistance and virulence factors, providing a more holistic view of pathogen behavior in clinical settings.

Declining or Waning

While the 'Journal of Pathogens' has maintained a strong focus on various core topics, certain areas have shown a decline in publication frequency or thematic emphasis. This shift may reflect changing research priorities or emerging challenges in the field.
  1. Traditional Antibiotic Studies:
    Research centered solely on traditional antibiotic efficacy without addressing resistance mechanisms or innovative treatment strategies has decreased, possibly due to the growing emphasis on understanding and combating antimicrobial resistance.
  2. Non-Clinical Studies:
    Papers focusing on purely theoretical or non-clinical aspects of pathogens without direct implications for treatment or public health have become less prominent, as the journal increasingly prioritizes studies with practical applications.
  3. Vector-Borne Diseases:
    There appears to be a waning focus on vector-borne diseases as the primary subject, as more recent publications have shifted towards bacterial and viral pathogens, particularly in the context of antibiotic resistance.

Similar Journals

Virulence

Leading the Charge in Virulence Research
Publisher: TAYLOR & FRANCIS INCISSN: 2150-5594Frequency: 8 issues/year

Virulence, a leading academic journal published by Taylor & Francis Inc, is dedicated to advancing the understanding of virulence mechanisms in pathogens across various infectious diseases. Since becoming an Open Access publication in 2018, it has broadened the accessibility of cutting-edge research for a global audience, promoting collaboration and knowledge-sharing among researchers, professionals, and students alike. With a significant impact within its field, the journal boasts impressive 2023 quartile rankings: Q2 in Immunology and Q1 in both Infectious Diseases and Microbiology, alongside notable standings in Parasitology. The current Scopus rankings reinforce its prominence, with high percentiles indicating its influence and relevance in advancing scientific inquiry. Covering a period from 2010 to 2024, Virulence serves as an essential platform for innovative research that not only addresses the critical challenges in understanding pathogen behavior but also contributes towards global health solutions, establishing it as a vital resource in the rapidly evolving fields of immunology, microbiology, and parasitology.

Infectious Microbes & Diseases

Unraveling the complexities of microbes and their impact.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

New Microbes and New Infections

Advancing knowledge on the frontlines of infectious diseases.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Revista Chilena de Infectologia

Pioneering insights into infectious challenges in Chile and beyond.
Publisher: SOC CHILENA INFECTOLOGIAISSN: 0716-1018Frequency: 6 issues/year

Revista Chilena de Infectologia is an esteemed academic journal dedicated to the field of infectious diseases and public health. Published by the SOC CHILENA INFECTOLOGIA, this journal has been pivotal in disseminating crucial research findings since its inception in 2000. While operating under ISSN 0716-1018 and E-ISSN 0717-6341, it aims to contribute to the understanding of both local and global health issues, particularly within the context of Chile. Currently, it holds a Q4 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories as of 2023, reflecting its unique position among emerging voices in the field. The journal aspires to foster collaboration among researchers, professionals, and students by offering a platform for innovative studies and discussions that address pressing health challenges. Although it is not an Open Access journal, access options through institutional subscriptions are encouraged for a comprehensive review of its significant contributions to infectious disease research.

BMC MICROBIOLOGY

Empowering the global microbiology community with open access knowledge.
Publisher: BMCISSN: 1471-2180Frequency: 1 issue/year

BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.

INFECTION AND IMMUNITY

Transforming Knowledge into Public Health Solutions
Publisher: AMER SOC MICROBIOLOGYISSN: 0019-9567Frequency: 12 issues/year

INFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.

Frontiers in Cellular and Infection Microbiology

Pioneering research for a healthier tomorrow.
Publisher: FRONTIERS MEDIA SAISSN: 2235-2988Frequency: 1 issue/year

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

New Microbiologica

Fostering innovation in the ever-evolving world of microbiological research.
Publisher: EDIZIONI INT SRLISSN: 1121-7138Frequency: 4 issues/year

New Microbiologica is a prominent academic journal published by EDIZIONI INT SRL, dedicated to advancing knowledge in the fields of Microbiology and Medicine. Since its inception in 1993, this journal has played a vital role in disseminating cutting-edge research, featuring articles that explore the intricate relationships between microorganisms and human health. With an H-index indicating a robust citation profile and a respectable 2023 Scopus Ranking placing it in the 32nd percentile for medicine microbiology, New Microbiologica resonates well within the academic community. Although not an Open Access journal, it is strategically positioned in Quartile 3 of both Medicine (miscellaneous) and Medical Microbiology categories, which reflects its importance to researchers and professionals seeking valuable insights in their fields. Published in Italy, the journal continues to provide a platform for impactful research through its commitment to high-quality publications, fostering collaboration and innovation among scientists and academics in the ever-evolving landscape of microbiological studies.

Mediterranean Journal of Infection Microbes and Antimicrobials

Innovating solutions for a healthier tomorrow.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Microbiology Spectrum

Bridging disciplines in the realm of microbiological studies.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.